BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33547612)

  • 21. miR-509-3-5P inhibits the invasion and lymphatic metastasis by targeting PODXL and serves as a novel prognostic indicator for gastric cancer.
    Zhang J; Zhu Z; Sheng J; Yu Z; Yao B; Huang K; Zhou L; Qiu Z; Huang C
    Oncotarget; 2017 May; 8(21):34867-34883. PubMed ID: 28432273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of miR-181d is associated with poor prognosis and tumor progression of gastric cancer.
    Li Z; Guo Q; Lu Y; Tian T
    Cancer Biomark; 2019; 26(3):353-360. PubMed ID: 31524144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of miR-141 downregulation in gastric cancer.
    Lu YB; Hu JJ; Sun WJ; Duan XH; Chen X
    Genet Mol Res; 2015 Dec; 14(4):17305-11. PubMed ID: 26681225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-1253, a novel tumor suppressor gene in colon cancer, is associated with poor patients prognosis.
    Yang D; Zhang D
    Clin Exp Med; 2021 Nov; 21(4):563-571. PubMed ID: 33837882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulation of miR-1266-5p serves as a prognostic biomarker of hepatocellular carcinoma and facilitates tumor cell proliferation, migration and invasion.
    Su Y; Xie R; Xu Q
    Acta Biochim Pol; 2021 May; 68(2):293-300. PubMed ID: 34006084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-937 inhibits cell proliferation and metastasis in gastric cancer cells by downregulating FOXL2.
    Yu L; Chen J; Liu Y; Zhang Z; Duan S
    Cancer Biomark; 2017 Dec; 21(1):105-116. PubMed ID: 29060929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN.
    Zhang BG; Li JF; Yu BQ; Zhu ZG; Liu BY; Yan M
    Oncol Rep; 2012 Apr; 27(4):1019-26. PubMed ID: 22267008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer.
    Xu M; Qin S; Cao F; Ding S; Li M
    Int J Oncol; 2017 Sep; 51(3):867-876. PubMed ID: 28713929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased Expression of MicroRNA-221 in gastric cancer and its clinical significance.
    Liu K; Li G; Fan C; Diao Y; Wu B; Li J
    J Int Med Res; 2012; 40(2):467-74. PubMed ID: 22613407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased expression of miR-601 is associated with poor prognosis and tumor progression of gastric cancer.
    Min C; Zhang A; Qin J
    Diagn Pathol; 2019 Sep; 14(1):107. PubMed ID: 31547835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer.
    Mu YP; Tang S; Sun WJ; Gao WM; Wang M; Su XL
    Asian Pac J Cancer Prev; 2014; 15(20):8893-900. PubMed ID: 25374225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low miR-1273a expression predicts poor prognosis of colon cancer and facilitates tumor cell proliferation, migration, and invasion.
    Sun L; Zhou X; Jiang Q; Zhuang Y; Li D
    Braz J Med Biol Res; 2021; 54(2):e10394. PubMed ID: 33439933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-31 inhibits tumor invasion and metastasis by targeting RhoA in human gastric cancer.
    Ge F; Wang C; Wang W; Liu W; Wu B
    Oncol Rep; 2017 Aug; 38(2):1133-1139. PubMed ID: 28656284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA ASMTL-AS1/microRNA-1270 differentiate prognostic groups in gastric cancer and influence cell proliferation, migration and invasion.
    Song Z; Wang J
    Bioengineered; 2022 Jan; 13(1):1507-1517. PubMed ID: 34986743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and prognostic value of microRNA-26a and microRNA-148a in gastric cancer.
    Qiu X; Zhu H; Liu S; Tao G; Jin J; Chu H; Wang M; Tong N; Gong W; Zhao Q; Qiang F; Zhang Z
    J Gastroenterol Hepatol; 2017 Apr; 32(4):819-827. PubMed ID: 27529338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastrokine 1 inhibits gastric cancer cell migration and invasion by downregulating RhoA expression.
    Yoon JH; Choi WS; Kim O; Choi BJ; Nam SW; Lee JY; Park WS
    Gastric Cancer; 2017 Mar; 20(2):274-285. PubMed ID: 27250838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [MiR-126 inhibits the proliferation and invasion of gastric cancer by downregulation of IGF-1R].
    Wang H; Wang G; Tian WL
    Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):508-515. PubMed ID: 31357837
    [No Abstract]   [Full Text] [Related]  

  • 38. miR-654-3p predicts the prognosis of hepatocellular carcinoma and inhibits the proliferation, migration, and invasion of cancer cells.
    Yang J; Zhang Z; Chen S; Dou W; Xie R; Gao J
    Cancer Biomark; 2020; 28(1):73-79. PubMed ID: 32176631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High miR-718 Suppresses Phosphatase and Tensin Homolog (PTEN) Expression and Correlates to Unfavorable Prognosis in Gastric Cancer.
    Liu S; Tian Y; Zhu C; Yang X; Sun Q
    Med Sci Monit; 2018 Aug; 24():5840-5850. PubMed ID: 30131483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
    Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
    Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.